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Absence of N-terminal 
acetyltransferase diversification 
during evolution of eukaryotic 
organisms
Om Singh Rathore1,2,3, Alexandra Faustino1,2, Pedro Prudêncio1,2,5, Petra Van Damme6,7, 
Cymon J. Cox4 & Rui Gonçalo Martinho1,2,5
Protein N-terminal acetylation is an ancient and ubiquitous co-translational modification catalyzed by 
a highly conserved family of N-terminal acetyltransferases (NATs). Prokaryotes have at least 3 NATs, 
whereas humans have six distinct but highly conserved NATs, suggesting an increase in regulatory 
complexity of this modification during eukaryotic evolution. Despite this, and against our initial 
expectations, we determined that NAT diversification did not occur in the eukaryotes, as all six major 
human NATs were most likely present in the Last Eukaryotic Common Ancestor (LECA). Furthermore, 
we also observed that some NATs were actually secondarily lost during evolution of major eukaryotic 
lineages; therefore, the increased complexity of the higher eukaryotic proteome occurred without a 
concomitant diversification of NAT complexes.
The genetic code is almost universal and the decoding molecular machine, the ribosome, is highly conserved 
across all known living organisms1. The narrow dimension of the ribosome exit tunnel (the cavity from which 
the nascent peptide emerges) precludes large domain folding of the nascent protein. This creates a window of 
opportunity for modification of protein residues that would be otherwise inaccessible due to folding. Indeed, 
co-translational modifications are widespread in cells throughout all three traditional kingdoms of life. Among 
others, these modifications include the proteolytic excision of the initial methionine and protein N-terminal 
acetylation (Nt-acetylation)2–4, which involves the transfer of an acetyl group from acetyl-CoA to the protein 
alpha-amino group4. Although Nt-acetylation is an ubiquitous modification in eukaryotes, its prevalence var-
ies, having a protein frequency of 50–70% in Saccharomyces cerevisiae (budding yeast), 70–80% in Drosophila 
melanogaster (fruit fly), and 80–90% in Homo sapiens (humans) and Arabidopsis thaliana (flowering plant)5–9. In 
eubacteria typically less than 10% of proteins are (partially) N-terminally acetylated, whereas in archaeal species 
it varies between 14–29% of all studied proteins3,10.
Nt-acetylation may influence protein half-life11–15, localization and export16,17, protein-protein and 
protein-lipid interactions18–22, the correct organization and function of the cellular cytoskeleton23–25, nuclear 
chromatin26,27, and vesicular compartment28. Its mis-regulation is frequently associated with tumor development 
and aggressiveness29, and distinct human syndromes30–33.
Nt-acetylation is catalyzed by a highly conserved family of N-terminal acetyltransferases (NATs). Prokaryotes 
have at least three NATs3,34–37, whereas H. sapiens has six distinct but highly conserved NATs (NatA-F) (Fig. 1A). 
While some of these NATs are protein complexes requiring different catalytic and auxiliary subunits (e.g. NatA, 
NatB, and NatC), other NATs are able to Nt-acetylate independently of protein partners (e.g. NatD, NatF, and 
possibly NatE)9,25,38–47. NATs have distinct substrate specificity profiles, where substrate recognition depends on 
the identity of the first 2–5 amino acids of the elongating polypeptide6,9,39,48–51.
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Nascent proteins are synthesized with a N-terminal methionine (also known as the initiator methionine 
or iMet), but if the second residue is non-bulky the iMet is frequently co-translationally removed by methio-
nine aminopeptidases and the second residue is Nt-acetylated by NatA6,49,50. If the iMet is not excised, it can 
be Nt-acetylated by the other NATs. NatA and NatB are the major NATs in eukaryotic cells, which together 
Nt-acetylate approximately 60% of all H. sapiens proteins, while NatC, NatE, and NatF together Nt-acetylate only 
15–20% of the proteome9,52. By contrast, the single archaeal NAT, possibly a direct ancestor of the eukaryotic 
NATs, has the ability to Nt-acetylate both NatA and NatE-type substrates of eukaryotes34. Such ancestral relation-
ship implies the evolution of NAT substrate specialization and diversification in the eukaryote lineage.
Although absent in S. cerevisiae, NatF has been identified in H. sapiens, D. melanogaster, and more recently 
in A. thaliana9,53. NatF enzymatic activity is responsible for a significant increase in proteome Nt-acetylation 
when comparing S. cerevisiae to H. sapiens9, and specifically targets transmembrane proteins28. Indeed, since 
the number and degree of Nt-acetylated proteins and NAT diversity is higher in H. sapiens and D. melanogaster 
Figure 1. All six major human NAT complexes (NatA-F) were most likely present in the Last Eukaryotic 
Common Ancestor (LECA). (A) Subunits of all six major human NAT complexes (NatA-F). Catalytic subunits 
are shown in green, whereas regulatory subunits are shown in orange. (B) Catalytic and regulatory subunits of 
all six major human NATs complexes were identified across the eukaryotic tree of life, suggesting they were all 
present in the LECA. NATs subunit orthologs were identified in 27 species representative of the eukaryotic tree 
of life59–63. Naa60 (NatF) was apparently secondarily lost in fungi. Results are indicated according to reciprocal 
blastp E-value score (“filled dot” = E-value score lower than e−8; “open dot” = E-value score between e−8-e−03; 
“no dot” = E-value score higher than e−03. Black dot indicates NAT was identified using H. sapiens ortholog; 
orange dot indicates that NAT was identified using S. cerevisiae ortholog; green, yellow and red dots indicate 
that NATs were identified, respectively, using the phylogenetically closest plant, excavate and chromalveolata 
species ortholog. In the case of species-specific gene duplication, the number of dots is equivalent to the number 
of identified NAT paralogs. Phylogenetic distribution shown in this figure was previously reported59–63. Details 
of the original 73 analyzed eukaryotic species are shown in Supplementary Fig. 1 and Supplementary Table 1.
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compared to S. cerevisiae and prokaryotes, it has been proposed that an increase in the regulatory complexity of 
this co-translational modification has occurred during evolution of higher eukaryotes9,28. Yet, the precise nature 
of these changes and their functional consequences remains poorly understood, as genome-wide studies across 
the eukaryotic tree of life are lacking.
In this work, we investigated the diversification of NATs during evolution of eukaryotic organisms. We con-
cluded that most diversification of NATs happened before the evolution of eukaryotes, as our data strongly sug-
gest that all six major human NATs were most likely present in the Last Eukaryotic Common Ancestor (LECA). 
Furthermore, we also observed that some NATs were secondarily lost during evolution of major eukaryotic lin-
eages. Therefore, and although some clade-specific NAT duplications exist across the eukaryotic tree of life54–56, 
the increased complexity of the higher eukaryotic proteome occurred without a concomitant diversification of 
the major NAT complexes.
Results
All six major human NATs (NatA-F) were most likely present in the Last Eukaryotic Common 
Ancestor (LECA). Since the number of distinct NAT complexes and N-terminally acetylated proteins 
increased in H. sapiens and D. melanogaster when compared to S. cerevisiae and prokaryotes3,9, we hypothesized 
that NATs had diversified during evolution of eukaryotic organisms. To test this hypothesis we selected 27 spe-
cies representative of the major clades of eukaryotic tree of life: seven holozoa, four fungi, two amoebozoans, 
five plants, four excavates, and five chromalveolata. Bidirectional protein BLAST57 searches and HMMER58 gene 
model analyses were used to assess the presence or absence of the putative catalytic and regulatory subunits of 
the six major H. sapiens NAT complexes, or when necessary, NATs orthologs from more closely related species 
(e.g. S. cerevisiae for analysis of most fungi species). We considered NAT subunits orthologs on the basis of 
E-value of reciprocal best-hit in blastp (Fig. 1B; Supplementary Table 1). Detailed results for the originally ana-
lyzed 73 eukaryotic species are shown in Supplementary Fig. 1 and Supplementary Table 1.
Our analysis identified orthologs for the catalytic and regulatory subunits of all six NatA-F complexes (respec-
tively, Naa10, Naa15, Naa20, Naa25, Naa30, Naa35, Naa40, Naa50, and Naa60) (Fig. 1A) in holozoa, amoebozoa, 
plantae, excavata, and chromalveolata (Fig. 1B). Consistent with our previous observation in S. cerevisiae9, we 
failed to detect Naa60 in the four fungi species (Fig. 1B). When considering the wide phylogenetic distribution of 
the analyzed eukaryotic species (Fig. 1B)59–63, we concluded that all major known H. sapiens NAT complexes were 
most likely present in the Last Eukaryotic Common Ancestor (LECA). Our results also suggested that Naa60 was 
secondarily lost in fungi (see below).
Identified NATs are most likely catalytically active. If the identified NATs are catalytically active, the 
acetyl-CoA binding domain and catalytically active residues should be conserved among these proteins. To test 
this hypothesis we performed multiple sequence alignment of the protein sequences encoding the catalytic sub-
units of NATs, guided by the recently identified substrate-binding and catalytically active residues of H. sapiens 
Naa10 and Naa5064,65. Full protein alignment of distinct NAT catalytic subunit identified multiple highly con-
served domains (data not shown). The acetyl coenzyme A binding motif, RxxGxG/A, is a sequence feature that 
is highly conserved among enzymes of the N-acyltransferase superfamily66,67 and is highly conserved in most 
NATs (Fig. 2C). The catalytically active residues of Naa10 (α 1–α 2 loop ‘E’; β 5 helix ‘R’; β 6-7 helix ‘Y’) and Naa50 
(β 4 helix ‘Y’; β 5 helix ‘H’) (“inverted triangles” indicated on Fig. 2A,B)64,65, and the substrate binding residues 
for Naa10 (α 1–α 2 loop ‘L’, ‘E’, and ‘Y’; β 6-7 helix ‘Y’) and Naa50 (α 1–α 2 loop ‘Y’; β 4 helix ‘M’; β 5 helix ‘H’; β 6-7 
helix ‘Y’) (“plus signs” indicated on Fig. 2A,B)64,65, were similarly highly conserved among most identified Naa10 
and Naa50 orthologs.
In addition, all major functional domains of Naa10 and Naa50 (α 1–α 2 loop, β 4, β 5 and β 6-7) were also 
highly conserved among Naa20, Naa30, and Naa60 (Fig. 2A,B). The only exception was Naa30, where the cata-
lytically active arginine (R) in the β 5 helix of Naa10 was replaced by a highly conserved glutamic acid (E) residue 
(Fig. 2A,B). Interestingly, the catalytically active glutamic acid (E) in α 1–α 2 loop and arginine (R) in the β 5 helix 
were flanked by residues that varied specifically between Naa10, Naa20, and Naa30 (Fig. 2A,B). This confirmed 
that most identified NATs were correctly assigned to Naa10, Naa20, and Naa30, and suggested that this motif var-
iation might be important for their distinct substrate specificities. Our results strongly suggest that most identified 
NATs are catalytically active N-terminal acetyltransferases. NATs whose canonical catalytically active residues 
vary from the H. sapiens orthologs are indicated in Supplementary Fig. 2.
Clade-specific NAT loss during evolution of eukaryotic organisms. Although all major NAT com-
plexes were most likely present in the LECA, we previously observed that Naa60 (the catalytic subunit of NatF) 
was absent in S. cerevisiae9. To test whether NatF is likely absent in all fungi, we analyzed 13 species representative 
of the fungal kingdom, and confirmed that Naa60 orthologs are absent (Fig. 3). The wide phylogenetic distribu-
tion of the analyzed fungal species suggests that Naa60 was most likely absent in the progenitor of all fungi.
We also investigated the genomes of species in the phylum microspora, as they are eukaryotic unicellular 
organisms and obligatory intracellular parasites that exhibit extreme genome reduction and gene loss68. We 
detected orthologs for Naa10, Naa20, and Naa50 in most microsporidia, yet we failed to identify orthologs for 
Naa30, Naa40, and Naa60 (Fig. 3). Loss of Naa40 and Naa60 was also observed within some but not all excavata 
(another large group of unicellular organisms) (Fig. 3). It is therefore evident that although all six NATs present in 
H. sapiens were most likely present in the LECA, some NATs have been lost during evolution of major eukaryotic 
lineages.
Surprisingly, in birds, we failed to identify Naa10 in galliformes (e.g. Gallus gallus (chicken) and 
Meleagris gallopavo (turkey)), passeriformes (e.g. Taenopygia guttata and Ficedula albicollis), and psittaci-
formes (e.g. Melopsittacus undulatus (budgerigar)) (Supplementary Fig. 4). However, given a) the extent of 
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conservation of Naa10 across the eukaryotic tree of life (Fig. 1B; Supplementary Fig. 1), b) NatA’s broad role 
in protein Nt-acetylation, c) the identification of the Naa10-interacting subunit Naa15 (Supplementary Fig. 1; 
Supplementary Fig. 4), d) the identification of methionine aminopeptidases (MetAP) in all tested bird species 
(data not shown), and e) that Naa10 is present in some other birds (e.g. Falco cherrug (falcon) and Anas platyrhyn-
chos (duck)) (Supplementary Fig. 1; Supplementary Fig. 4), we concluded that the absence of Naa10 in some birds 
is probably due to an unknown gap in the publicly available genome data. Undetectable Naa10 homologs due to 
rapid sequence divergence is not likely an explanation, as the protein sequences of the two identified birds’ Naa10 
were highly conserved (Supplementary Table 1).
NatE interacts and influences in vivo NatA catalytic activity. Naa10 and Naa20 were never or rarely 
lost during eukaryotic evolution (Fig. 1; Supplementary Fig. 1), even in organisms like microsporidia with exten-
sive gene loss (Fig. 3)68, possibly because these two NATs Nt-acetylate the majority of the proteome9,52, likely 
Figure 2. Identified NATs are most likely catalytically active. Identified NATs are most likely catalytically 
active as the acetyl-CoA binding domain66,67 and the catalytically active residues from H. sapiens NAT´s64,65 
are highly conserved among these proteins. Protein sequences were retrieved from the genomes of 73 species 
representative of the eukaryotic tree of life and aligned. Letters height represents the degree of conservation of 
each amino acid residue for that position. The catalytically active residues (▼ ) and substrate binding residues (+ ) 
for Naa10 and Naa50 are indicated above each sequence alignment64,65. (A and B) The catalytically active residues 
of Naa10 (α 1–α 2 loop ‘E’; β 5 helix ‘R’; β 6-7 helix ‘Y’) and Naa50 (β 4 helix ‘Y’; β 5 helix ‘H’) are highly conserved 
among most identified NATs. The substrate binding residues for Naa10 (α 1–α 2 loop ‘L’, ‘E’, and ‘Y’; β 6-7 helix 
‘Y’) and Naa50 (α 1–α 2 loop ‘Y’; β 4 helix ‘M’; β 5 helix ‘H’; β 6-7 helix ‘Y’) are also highly conserved among most 
identified NATs. The substrate binding and catalytically active residues of Naa10 are similarly highly conserved in 
Naa20 and Naa30. The only exception is the catalytically active arginine (R) in the β 5 helix, which was replaced 
in Naa30 by a highly conserved glutamic acid (E) residue. The catalytically active glutamic acid (E) in α 1–α 2 
loop and arginine (R) in the β 5 helix are flanked by residues that vary specifically within Naa10, Naa20, and 
Naa30. (C) The acetyl coenzyme A binding motif, RxxGxG/A, which is highly conserved among enzymes of the 
N-acyltransferase superfamily66,67, is similarly conserved among most identified NATs.
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making them indispensable. Surprisingly, Naa50 was comparatively more resilient to loss in distinct eukaryotic 
lineages than Naa30, Naa40, and Naa60 (Fig. 3; Supplementary Fig. 1).
Drosophila Naa50 is encoded by the gene separation anxiety (san) and is required for sister chromatid cohe-
sion and chromosome segregation during mitosis69,70. Consistently with previous reports69,71,72, Naa50 (~20kDa) 
physically interacted with NatA (Naa10 and Naa15; respectively ~22kDa and ~103kDa) (Fig. 4A,B). Naa10 and 
Naa50-containing complexes of approximately 150-350kDa were identified in wild-type Drosophila embryos 
(Fig. 4D), next to the detection of significant levels of monomeric Naa50. There was however no notable change 
in the apparent size of the Naa10-containing complexes in protein extracts from san3 mutant embryos (Fig. 4C 
versus 4D), which suggested that NatA complex integrity was not affected by loss of Naa50.
The NatA-interacting chaperone-like protein HYPK73 was also identified as a subunit of the immunoprecipi-
tated Naa50-containing complex (Fig. 4B), suggesting that Naa50 interacts (directly or indirectly) not only with 
Naa10-Naa15 but also with a subset of other NatA-interacting proteins. This supports the hypothesis that the 
relative levels of ribosome associated Naa50/NatA and MetAPs (iMet-aminopeptidases) are important for the 
correct processing of the nascent polypeptide N-termini74 and further confirms the functional crosstalk between 
these two NAT complexes.
Figure 3. Clade-specific NAT loss during evolution of eukaryotic organisms. NAT complexes have been 
secondarily lost during evolution of major eukaryotic lineages. Naa10 and Naa20 were never or seldom lost 
during eukaryotic evolution (Fig. 1) (Supplementary Fig. 1), even in organisms like microsporidia with extensive 
gene loss68. Naa50 was comparatively more resilient to loss in distinct eukaryotic lineages (e.g. microspora and 
excavata) than Naa30, Naa40, and Naa60. Analysis of 13 species representative of the fungal kingdom shows 
that Naa60 is absent. The wide phylogenetic distribution of the fungal taxa suggests that Naa60 was most 
likely absent in the progenitor of all fungi. Results are indicated according to reciprocal blastp E-value score 
(“filled dot” = E-value score lower than e−8; “open dot” = E-value score between e−8-e−03; “no dot” = E-value 
score higher than e−03. Black dot indicates NAT was identified using H. sapiens ortholog; orange dot indicates 
that NAT was identified using S. cerevisiae ortholog; blue and yellow dots indicate that NATs were identified, 
respectively, using the phylogenetically closest microsporidia and excavate species ortholog. In the case of 
species-specific gene duplication, the number of dots is equivalent to the number of identified NAT paralogs. 
Phylogenetic distribution shown in this figure was previously reported59–63.
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Since the physical interaction between NatA and NatE (Naa50) is conserved between D. melanogaster and H. 
sapiens, and in line with the recent observation that six canonical NatA substrates were less Nt-acetylated in S. cer-
evisiae lacking Naa5074, we hypothesized that Naa50 was infrequently lost during eukaryotic evolution because its 
absence partially inhibits NatA enzymatic activity. To further support this hypothesis, we performed N-terminal 
Figure 4. NatE interacts and influences in vivo NatA catalytic activity. Drosophila Naa50 is encoded by the 
gene separation anxiety (san). Naa50 physically interacts with NatA, and its loss influences the in vivo activity 
of NatA. (A and B). Naa50 (~20 kDa) physically interacts with NatA complex (Naa10 and Naa15) and HYPK/
CG9922; respectively ~22 kDa, ~103 kDa, and ~14 kDa). Immunoprecipitated proteins were identified by 
western-blot (A) or by liquid chromatography coupled to tandem mass spectrometry (B). (C and D). Integrity 
of Naa10-containing complexes was apparently not affected after loss of Naa50. Size-exclusion chromatography 
of san3 mutant (C) and control (D) protein extracts from 0–2 h embryo collections. After separation, each 
fraction was analyzed by western blot. Naa10-containing complexes with approximately 150–350kDa were 
similarly identified in wild type and san3 mutant embryos (D versus C). There were significant levels of 
monomeric Naa50 (~20 kDa) in wild-type embryos (D). (E and F) Loss of Naa50 negatively influences the 
in vivo activity of NatA. The proteome of control and san3 maternal mutant embryos (0–2h collection) was 
analyzed by N-terminal COFRADIC75,89. (E) The N-terminal acetylation status of 265 unique N-termini was 
unequivocally determined, and the affected N-termini are shown for control (green bars) and san3 mutant 
embryos (blue bars). (F) Consensus sequence of affected N-termini suggested that most displayed a NatA-like 
substrate specificity (i.e. predominantly Thr-, Val-, Ser-, and Ala-starting N-termini). Only two of the affected 
N-termini started with a methionine (MF- and MQ-) (see asterisks indicated in panel E), which is consistent 
with the H. sapiens Naa50 substrate specificity39,74.
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COmbined FRActional DIagonal Chromatography (COFRADIC) analysis75 on the proteomes isolated from con-
trol and san3 maternal mutant Drosophila embryos to assay their Nt-acetylomes, and to look for differences in 
N-terminal acetylation states. The in vivo N-terminal acetylation levels of 265 proteins were unequivocally deter-
mined in the proteomes of both control and san3 mutant embryos (Fig. 4E,F). 18 protein N-termini were iden-
tified as more Nt-acetylated in the control proteome expressing Naa50 as compared to the san mutant proteome 
(absence of Naa50). Consistent with our hypothesis, 16 out of 18 of the san mutant affected N-termini displayed 
NatA-like substrate specificity (Fig. 4E,F). Only two affected N-termini started with a methionine (MF- and 
MQ- starting N-termini) (see asterisks on Fig. 4E), the presumed H. sapiens Naa50 substrate specificity39,74. This 
suggests that loss of Naa50 in D. melanogaster embryos was associated in vivo with a reduction of NatA activity, 
which fully supports the hypothesis that Naa50 was infrequently lost during eukaryotic evolution because its 
absence partially impairs NatA enzymatic activity.
No detectable proteome adaptation to NAT loss. NAT substrate specificity is largely defined by the 
identity of the substrate N-terminal second amino acid residue6,9,39,48–51,76. Since different NATs have distinct sub-
strate specificities, and since these enzymes Nt-acetylate a large number of proteins, we tested whether the loss 
of NatC, NatD, and NatF in microsporidia was associated with a detectable decrease of their substrate N-termini 
when compared to NatA and NatB substrate N-termini. To investigate if there was such proteome-wide adap-
tation to NAT loss, we analyzed the amino acid frequency in N-terminal second, third, fourth, fifth, and sixth 
residue positions for 36 species representative of the eukaryotic tree of life, including 5 microsporidia species.
Previously, it was observed that the amino acid preference for the N-terminal second position varies, being 
lysine the most common amino acid residue in prokaryotes, serine the most common for lower eukaryotes, 
and alanine the most common for animals9,52,77,78. Consistently, we identified major biases in the frequency of 
amino acid usage at the N-terminal second position within distinct eukaryotic clades, including vertebrates and 
plants (Fig. 5; Supplementary Fig. 5; Supplementary Table 2). In vertebrates and plants, alanine residues (NatA 
Figure 5. No detectable proteome adaptation to NAT loss. There are major biases in the frequency of 
amino acid usage at the N-terminal second position when compared to total proteome. However there is no 
detectable proteome adaptation to NAT loss. Loss of NatC and NatF in microsporidia (blue dots) and in some 
excavata (yellow dots) (Fig. 3) does not correlate with an increase usage frequency of NatA and NatB substrates. 
Comparatively to holozoans (black dots) and fungi (orange dots), microsporidia show an under-representation 
of alanine and serine residues (NatA substrates), no obvious over-representation of NatB substrates, and 
comparatively to higher eukaryotes, a moderate over-representation of lysine (NatC and NatE substrates). 
Amino acid usage frequency bias for each N-terminal position was analyzed by calculating the amino acid 
usage frequency for each position divided by its frequency in the total proteome (for more experimental detail 
see material and methods). The fold enrichment heat map shows the over-representation range (1 to 3.87 fold 
enrichment) of each amino acid at the N-terminal second position when compared to the total proteome. For 
each species and for each amino acid, it was attributed a black color (≤ 1.0) when the amino acid is under-
represented in the N-terminal second position compared to its total proteome usage frequency. A detailed 
breakdown of the values used in this heat map is shown in Supplementary Table 2.
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substrate6,7,50) were significantly over-represented in the N-terminal second position when compared to the total 
frequency of usage of this amino acid in the proteome (Fig. 5; Supplementary Table 2), whereas serine residues 
(NatA substrate6,7,50) were significantly over-represented in the N-terminal second position of fungi and excavates 
(Fig. 5; Supplementary Table 2). Invertebrates showed instead an over-representation of both alanine and serine 
residues in the N-terminal second position (Fig. 5; Supplementary Table 2)9. Other amino acid residues like leu-
cine, although commonly used in the entire proteome52, were nevertheless significantly under-represented at this 
position (data not shown). The N-terminal residue usage frequency biases were significantly less pronounced for 
the third, fourth, fifth and sixth N-terminal amino acid residues (Supplementary Fig. 5; Supplementary Table 2).
The N-terminal second residue position frequency bias observed in microsporidia does not support the 
hypothesis of a proteome-wide adaptation to loss of NatC, NatD, and NatF, with an increase frequency of NatA 
and NatB substrate N-termini. Compared to higher eukaryotes, microsporidia showed an under-representation 
of alanine and serine (NatA substrates), no obvious over-representation of NatB substrates, and a moderate 
over-representation of lysine (NatC and NatE substrates9,23,25,39,76). The moderate over-representation of lysine 
within these microorganisms is most likely not related to NAT loss, as the diatom Phaeodactylum tricornutum 
(chromalveolata), for example, showed an unusual over-representation of lysine within the N-terminal second 
position (Fig. 5) without NAT loss (Fig. 1). Some microsporidia, amoebozoa, chromalveolata, and excavata 
microorganisms also showed a moderate increase in the usage frequency of asparagine and glutamine residues 
(NatB substrates) in the N-terminal second position (Fig. 5). This over-representation is most likely also not 
related with NAT loss as Paramecium tetraurelia (chromalveolata), for example, showed a significant increase of 
these two residues (Fig. 5) without extensive NAT loss (Fig. 1). Consistently, differences in S. cerevisiae N-terminal 
sequences could not explain the absence of NatF in this unicellular organism9.
We concluded that although the N-terminal second residue position is under significant clade-specific 
constraints when compared to other nearby residues, there is no evidence supporting the hypothesis of a 
proteome-wide adaptation of proteins N-termini to NAT loss. The extensive loss of NATs might be accommo-
dated by an increased substrate redundancy of the remaining NATs in microsporidia. Alternatively, it is also 
possible that Nt-acetylation is not functionally rate limiting for most proteins.
Discussion
The origin of eukaryotes is still poorly understood. The organizational complexity of a eukaryotic cell is sig-
nificantly higher than any known prokaryote. Eukaryotic cell compartmentalization is supported by an elab-
orate endomembrane system and by an actin/tubulin-based cytoskeleton. Conservation of the major features 
of eukaryotic cell organization and of a large set of genes demonstrates that they were already present in the 
Last Eukaryotic Common Ancestor (LECA)79. Protein Nt-acetylation is an ancient and highly conserved protein 
modification. Although the number of NAT complexes significantly increased in eukaryotic cells when compared 
to prokaryotic organisms, our work demonstrates that all major human NAT complexes diversified before the 
evolution of eukaryotic organisms, as they were already present in LECA.
Clade-specific NAT duplications exist across the eukaryotic tree of life54–56. In mammals, gene duplications 
of both Naa10 and Naa15 resulted in Naa11 and Naa16 paralogs, respectively54,55. Both gene paralogs encode 
proteins that are likely to participate in functional NatA complexes. Although human Naa11 and Naa16 share 
81% and 70% sequence identity with Naa10 and Naa15, respectively54,55, Naa16 expression is particularly high 
on certain tissues like adrenal gland, mammary gland, heart, thymus, and testis55. Expression of mouse Naa11 
is similarly restricted, being particularly high during spermatogenesis80. Since mouse Naa10 locates on chromo-
some X, Naa11 expression is likely to have a compensatory function after the loss of Naa10 expression (approx-
imately in 50% of the sperm) during meiosis. Therefore, and although the increased complexity of the higher 
eukaryotic proteome clearly occurred without a concomitant diversification of the major known NAT complexes, 
clade-specific gene duplications likely happened to address specific functional requirements.
It is possible to argue that the NAT substrate repertoire has not been significantly increased during eukaryotic 
evolution, as these enzymes mostly rely on the identity of the substrate N-terminal second residue for specific-
ity. Nevertheless, and next to purely housekeeping functions for Nt-acetylation, the regulatory complexity of 
this co-translational modification is likely to have increased in higher eukaryotes as their proteome and cellu-
lar behavior became more complex. Consistently, detectable co-evolution between NATs substrate specificities 
and the eukaryotic proteome has recently been reported in humans for NatA and NatD47,81. In the absence of 
NAT diversification, we speculate that transcriptional and post-transcriptional regulation of NAT activity are 
likely to play increasingly important roles in the regulation of Nt-acetylation during development of multicellular 
organisms82.
Material and Methods
Identification of NAT orthologs. Reference protein sequences of NAT complexes subunits (Naa10, Naa15, 
Naa20, Naa25, Naa30, Naa35, Naa40, Naa50 and Naa60) in H. sapiens and S. cerevisiae were obtained through 
literature mining9,83. These sequences, or sequences from closely related species, were used to identify putative 
orthologs from 73 species (Supplementary Fig. 1) representative of the eukaryotic tree of life59–63. Publicly avail-
able genome databases (e.g. NCBI and Ensembl) were used to retrieve these sequences. Two steps were used to 
verify the identity of these putative orthologs: we used reciprocal bidirectional protein BLAST (blastp)57. The 
retrieved proteins were only considered bona fide orthologs if they corresponded to the blastp best hit in both 
directions. The results were subjectively divided in three classes: “filled dot”: reciprocal blastp E-value score lower 
than e−8; “empty dot”: reciprocal blastp E-value score between e−8- e−03; “no dot”: reciprocal blastp E-value scores 
higher than e−03 (Fig. 1B, Fig. 3, Supplementary Fig. 1–4, Supplementary Table 1). To identify apparently missing 
ortholog sequences, additional searches were performed using protein sequence queries from phylogenetically 
closely related organisms. For example, Populus trichocarpa (seed plant) protein sequences were used for ortholog 
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identification in the closely related (in the context of eukaryotes) Osteococcus tauri (green algae). To confirm the 
bidirectional blastp results, we built a separate hidden markov model for each NAT protein using HMMER 3.058. 
Multiple sequence alignments of ortholog protein sequences positively identified by reciprocal BLAST searches 
were used to calculate hidden markov models from GenBank non-redundant (nr) protein database (downloaded 
August 2013). These HMM profiles allowed us to review the fit of the sequence to our orthologue classification.
Sequence alignment and functional domain arrangement. For the identification of conserved 
domains within NAT catalytic subunits all identified orthologs of Naa10, Naa20, Naa30, Naa50, and Naa60 
were retrieved from 73 eukaryotic species and aligned using ClustalW84 program in the Geneious software (ver-
sion 6.1.8) with default values. Sequence alignments were manually edited by removing ambiguously aligned 
sequences and gaps in Gblocks85. Regions in the alignment with more than 50% gaps were removed. Four 
domains α 1–α 2 loop, β 4 helix, β 5 helix and β 6-7 helix were previously shown to be catalytically important in 
NATs64,65. These highly conserved domains were used to validate the alignment. The three catalytically active 
residues of Naa10 (α 1–α 2 loop ‘E’, β 5 helix ‘R’ and β 6-7 helix ‘Y)’ were identified and marked as (▼ ) (Fig. 2A,B). 
Substitution of the canonical catalytically active residues for alternative residues is shown in Supplementary 
Figs 2 and 3. The two catalytically active residues of Naa50 (β 4 helix ‘Y’ and β 5 helix ‘H’) were marked as (▼ ) 
(Fig. 2A,B). The acetyl coenzyme A (AcCoA) binding motif66,67, RxxGxG/A in NATs was manually assigned in 
the aligned sequences (Fig. 2C).
Fly work and genetics. Drosophila melanogaster flies were raised using standard techniques86. san3 mutant 
allele was previously reported as a loss-of-function allele of the gene separation anxiety (san)70, which encodes 
Drosophila Naa50. Maternal mutant embryos of san3 were generated using the FLP/FRT ovoD system87.
The Naa50 open-reading frame (from cDNA clone AT27602) was subcloned into a vector containing the 
UASp promoter and C-terminal Protein A-tag (Gateway, Life Technologies). All constructs were then used to 
generate transgenic fly stocks (BestGene).
Protein extracts. Collections of 0–2 hr (after egg-laying) Drosophila embryo were washed in PBS + 0.1% 
tween 20, dechorionated with 50% of bleach (commercial solution) for 5 minutes, and thoroughly washed in 
water. Protein extraction was performed through homogenization of embryos in NB lysis buffer (150 mM NaCl, 
50 mM Tris-HCl pH 7.5, 2 mM EDTA, 0.1% NP-40), 1 mM DTT, 10 mM NaF, and EDTA-free protease inhibitor 
cocktail (Roche, Germany). Extracts were centrifuged at 4 °C and 21,100 g for 3 minutes. Supernatant was col-
lected (being the upper lipid-rich layer avoided as much as possible) and centrifuged twice more. Total protein 
concentration was determined using Bio-Rad Bradford protein assay (BioRad, Hercules, CA, USA).
Antibodies. Primary antibodies used were rabbit anti-San/Naa50 (1:1000)69 and rabbit anti-Ard1/Naa10 
(1:2000) (Santa Cruz; FL-235)88. Secondary detection in western-blot was performed with rabbit HRP-conjugated 
antibodies (Jackson ImmunoResearch) used at a final concentration of 1:5000.
Co-Immunoprecipitation. Total proteins extracts of Drosophila embryos expressing Naa50/San fused to a 
C-terminal Protein A-tag (Naa50/San-PA) were obtained. Dynabeads M-270 Epoxy (Invitrogen, Grand Island, 
NY, USA) pre-incubated with rabbit IgG immunoglobulins (5 μ g IgGs/ 1 mg of beads) (Dynabeads antibody 
coupling kit, 14311D, Invitrogen), were added to 1.5 mg of protein extract and incubated for 1 hour at 4 °C. 
After washing the beads 3 times with NB buffer, protein elution was performed with 100 μ l of 100 mM Glycine 
pH 3.0 during 1 minute and stopped with 10 μ l of 1 M Tris Base pH 10.8. Eluted proteins were precipitated at 
− 20 °C using 5 volumes of acetone. Precipitated samples were analyzed by liquid chromatography coupled to 
tandem mass spectrometry (Mass Spectrometry Laboratory, Institute of Biochemistry and Biophysics, Poland). 
For western-blot analysis eluted proteins were boiled in SDS-sample buffer for 5 minutes.
Size exclusion chromatography. Size-exclusion chromatography was performed by applying protein 
extracts of 0–2 h collections from FRT42B san3 mutants or control (Oregon R) Drosophila embryos. Extracts 
were prepared in NB2 buffer (150 mM NaCl, 50 mM Tris-HCl pH 7.5, 2 mM EDTA, 0.01% NP-40), 1 mM DTT 
and EDTA-free protease inhibitor cocktail (Roche). Subsequently, 2 mg of protein extract were fractionated using 
Superose 6 10/300 GL column (GE Healthcare) in NB2 buffer and analyzed by western blot using antibodies 
against Naa10/Ard188 and Naa50/San.
Mass spectrometry. Liquid chromatography coupled to tandem mass spectrometry was performed at the 
Mass Spectrometry Laboratory (Institute of Biochemistry and Biophysics, Poland).
Briefly, peptides mixtures were analyzed by LC-MS-MS/MS (liquid chromatography coupled to tandem 
mass spectrometry) using Nano-Acquity (Waters, Milford, MA, USA) LC system and Orbitrap Velos mass spec-
trometer (Thermo Electron Corp., San Jose, CA, USA). Prior to analysis, proteins were subjected to standard 
‘in-solution digestion’ procedure, during which proteins were reduced with 100 mM DTT (for 30 minutes at 
56 °C), alkylated with 0.5 M iodoacetamide (45 minutes in darkroom at room temperature), and digested over-
night with trypsin (Sequencing Grade Modified Trypsin-Promega V5111). The peptide mixture was applied to 
an RP-18 precolumn (nanoACQUITY Symmetry C18-Waters 186003514) using water containing 0.1% TFA as 
mobile phase, then transferred to nano-HPLC RP-18 column (nanoACQUITY BEH C18-Waters 186003545) 
using an acetonitrile gradient (0%–35% AcN in 180 min) in the presence of 0.05% formic acid with a flow rate of 
250 nl/min. The column outlet was directly coupled to the ion source of the spectrometer, operating in the regime 
of data dependent MS to MS/MS switch. A blank run ensuring no cross contamination from previous samples 
preceded each analysis.
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Raw data were processed by Mascot Distiller followed by Mascot Search (Matrix Science, London, UK, on-site 
license) against Flybase database. Search parameters for precursor and product ions mass tolerance were 15 
ppm and 0.4 Da, respectively, enzyme specificity: trypsin, missed cleavage sites allowed: 0, fixed modification 
of cysteine by carbamidomethylation, and variable modification of methionine oxidation. Peptides with Mascot 
Score exceeding the threshold value corresponding to < 5% false positive rate, calculated by Mascot procedure, 
and with the Mascot score above 30 were considered to be positively identified.
N-terminal COFRADIC analysis. The proteome of control (Oregon R) and san3 maternal mutant 
Drosophila embryos (0–2 h collection) were analyzed by N-terminal COFRADIC analysis as described pre-
viously75,89. Overall, 432 unique N-termini derived from 399 unique SwissProt Drosophila protein accessions 
were identified. N-termini that partially retain their initiator-Met and/or have most probably alternative or 
miss-annotated translation products led to the higher number of unique N-termini as compared to their cor-
responding identified accession. Quantification of the degree of Nt-acetylation was performed as described9. A 
significant variation in the degree of Nt-acetylation was set to 10% or more (p ≤ 0.01). Further, N-termini were 
considered to be affected by san deletion that were fully acetylated in the control strain and displayed a reduction 
of more than 5% in the san deletion strain were also considered.
As such, the N-terminal acetylation states of the N-termini identified in both setups (292 unique N-termini) 
were comparatively analyzed. In this study we distinguished between in vivo N-terminal acetylation and free 
N-termini by making use of in vitro AcD3C13-acetylation (i.e. 5Da heavier form of NHS-acetate which intro-
duces an 13C2 and D3 labeled acetyl moiety on all free amines).
An N-terminus is defined as 1) a peptide that is in vivo N-terminal acetylated or in vitro AcD3C13-acetylated 
peptide (i.e. an in vivo free N-terminus) and starts in the Swiss-Prot database at position 1 or 2 of the annotated 
protein sequence, or 2) an in vivo N-terminal acetylated peptide, with a protein sequence starting position beyond 
position two. Only peptides displaying an internal start position and of which at least one N-terminal acetylated 
peptide was identified in one of the two setups analyzed were considered (i.e. internal AcD3C13-acetylated pep-
tides were not considered in this study).
Overall the N-terminal acetylation levels of 265 out of the 292 unique N-termini identified in both setups 
could be unequivocally determined in control as well as the san mutant setup, and for the affected N-termini, 
the difference (∆) in the N-terminal acetylation status of the control versus san mutant setup was analyzed and 
is shown (Fig. 4E). In total, 10 unique N-termini (start 1/2) and 4 N-termini (internal start position) displayed 
in san mutant embryos a decrease of at least 10% in the overall N-terminal acetylation. 12 out of 14 (or 87%) 
of the san mutant affected N-termini displayed NatA-like substrate specificity (i.e. predominantly Thr (8/14 or 
57%), Ser, Val and Ala-starting N-termini (Fig. 4F). Two affected N-termini started with a methionine (MF- and 
MQ- starting N-termini) (see “stars” in Fig. 4E). 4 unique N-termini displayed a decrease of more than 5% (but 
less than 10%) in the overall N-terminal acetylation. All four N-termini displayed NatA-like substrate specificity. 
LC-MS/MS analysis, data processing and storage were performed as described9.
Whole proteome sequences and frequency analysis. We selected 38 species (ten holozoa, seven plant, 
five fungi, five microsporidia, four excavata, five chromalveolata, and two amoeboza) to cover the full range 
of eukaryotic proteome complexity. Whole datasets of proteins from these organisms with complete proteome 
annotations available in UniProt were downloaded as FASTA formats in April 2015 (http://www.uniprot.org). We 
used reviewed (UniProtKB/Swiss-Prot) and unreviewed (UniProtKB/TrEMBL) protein entries for each analyzed 
species. Yet, if the reviewed proteome had less than thousand proteins than only the more extensive unreviewed 
proteome was used.
We analyzed the amino acid residue frequency bias (over or under-representation) for each N-terminal posi-
tion by calculating the residue frequency for each N-terminal position divided by the total proteome frequency of 
this residue (program script for N-termini analysis is available upon request). MultiExperiment Viewer (MeV), 
which is part of the TM4 Microarray Software Suite (v4.9), was used to perform hierarchical clustering and to 
generate heat maps with frequency of amino acid at second, third, fourth fifth, and sixth position90. The parame-
ters used for the hierarchical clustering were the sample tree, Pearson correlation and the average linkage method.
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